XML 36 R23.htm IDEA: XBRL DOCUMENT
v3.25.1

Research and Development Activity (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Research and Development Activity [Abstract] |
Schedule of INKmune License Agreement Milestone Payments in Consideration for the Patent Rights | In consideration for the patent rights, the Company agreed to the following milestone payments:
(in thousands) |  |  |
Each Phase I initiation |  | $ | 25 |
Each Phase II initiation |  | $ | 250 |
Each Phase III initiation |  | $ | 350 |
Each NDA/EMA filing |  | $ | 1,000 |
Each NDA/EMA awarded |  | $ | 9,000 |
Schedule of PITT Agreement Licensee is Required to make Milestone Payments | Moreover, under the PITT Agreement the Licensee is required to make milestone payments as follows:
(in thousands) |  |  |
Each Phase I initiation |  | $ | 50 |
Each Phase III initiation |  | $ | 500 |
First commercial sale of product making use of licensed technology |  | $ | 1,250 |

X
- Definition The tabular disclosure of the license agreement. + References No definition available. + Details
Name: | inmb_ScheduleOfLicenseAgreementTableTextBlock
Namespace Prefix: | inmb_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The tabular disclosure of milestone payments. + References No definition available. + Details
Name: | inmb_ScheduleOfLicenseeIsRequiredToMakeMilestonePaymentsTableTextBlock
Namespace Prefix: | inmb_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration